Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy.

Glomerular apoptosis may contribute to diabetic nephropathy (dNP), but the pathophysiologic relevance of this process remains obscure. Here, we administered two partially disjunct polycaspase inhibitors in 8-week-old diabetic (db/db) mice: M-920 (inhibiting caspase-1, -3, -4, -5, -6, -7, and -8) and CIX (inhibiting caspase-3, -6, -7, -8, and -10). Notably, despite reduction in glomerular cell death and caspase-3 activity by both inhibitors, only M-920 ameliorated dNP. Nephroprotection by M-920 was associated with reduced renal caspase-1 and inflammasome activity. Accordingly, analysis of gene expression data in the Nephromine database revealed persistently elevated glomerular expression of inflammasome markers (NLRP3, CASP1, PYCARD, IL-18, IL-1β), but not of apoptosis markers (CASP3, CASP7, PARP1), in patients with and murine models of dNP. In vitro, increased levels of markers of inflammasome activation (Nlrp3, caspase-1 cleavage) preceded those of markers of apoptosis activation (caspase-3 and -7, PARP1 cleavage) in glucose-stressed podocytes. Finally, caspase-3 deficiency did not protect mice from dNP, whereas both homozygous and hemizygous caspase-1 deficiency did. Hence, these results suggest caspase-3-dependent cell death has a negligible effect, whereas caspase-1-dependent inflammasome activation has a crucial function in the establishment of dNP. Furthermore, small molecules targeting caspase-1 or inflammasome activation may be a feasible therapeutic approach in dNP.

[1]  B. Dasgupta,et al.  Improved renal function in diabetic patients with acute gout treated with anakinra. , 2015, Kidney international.

[2]  T. Yoo,et al.  Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions , 2015, Apoptosis.

[3]  K. Schroder,et al.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.

[4]  F. Shao,et al.  Non-canonical activation of inflammatory caspases by cytosolic LPS in innate immunity. , 2015, Current opinion in immunology.

[5]  B. Friguet,et al.  Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet , 2015, Circulation.

[6]  Sarah L. Doyle,et al.  Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives , 2015, Journal of inflammation research.

[7]  K. Reymann,et al.  Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy , 2014, Kidney international.

[8]  Z. Dong,et al.  Regulated cell death in AKI. , 2014, Journal of the American Society of Nephrology : JASN.

[9]  K. Boini,et al.  Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin. , 2014, The American journal of pathology.

[10]  C. Pollock,et al.  Role of Toll-like receptors in diabetic nephropathy. , 2014, Clinical science.

[11]  Y. Hung,et al.  Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis , 2014, Diabetologia.

[12]  M. Shong,et al.  Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes , 2012, Diabetes.

[13]  Moshe Arditi,et al.  Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.

[14]  E. Donadi,et al.  Polimorphisms in Inflammasome Genes Are Involved in the Predisposition to Systemic Lupus Erythematosus , 2012, Autoimmunity.

[15]  Jinfeng Liu,et al.  Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.

[16]  A. Aderem,et al.  Caspase‐1‐induced pyroptotic cell death , 2011, Immunological reviews.

[17]  T. Madhusudhan,et al.  Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. , 2011, Blood.

[18]  J. Tschopp,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[19]  T. Yoo,et al.  Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. , 2009, Kidney international.

[20]  S. Janssens,et al.  Brief Definitive Report Stimulation of Toll-like Receptor 3 and 4 Induces Interleukin-1 ␤ Maturation by Caspase-8 , 2022 .

[21]  Matthias Kretzler,et al.  Defining human diabetic nephropathy on the molecular level: Integration of transcriptomic profiles with biological knowledge , 2008, Reviews in Endocrine & Metabolic Disorders.

[22]  Guanghui Liu,et al.  Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. , 2008, Biochemical and biophysical research communications.

[23]  C. Esmon,et al.  Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis , 2007, Nature Medicine.

[24]  M. Exline,et al.  Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. , 2006, American journal of respiratory and critical care medicine.

[25]  B. Cookson,et al.  Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells , 2005, Infection and Immunity.

[26]  K. Schulze-Osthoff,et al.  Apoptosis-based therapies and drug targets , 2005, Cell Death and Differentiation.

[27]  K. Burns,et al.  Evidence of apoptosis in human diabetic kidney , 2004, Molecular and Cellular Biochemistry.

[28]  R. Hotchkiss,et al.  Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.

[29]  G. Baxter,et al.  Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury , 2000, British journal of pharmacology.

[30]  P. Vandenabeele,et al.  Non‐specific effects of methyl ketone peptide inhibitors of caspases , 1999, FEBS letters.

[31]  T. Wada,et al.  Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells. , 2015, Kidney international.

[32]  M. Lamkanfi,et al.  Caspase-7: a protease involved in apoptosis and inflammation. , 2010, The international journal of biochemistry & cell biology.

[33]  M. Schiffer,et al.  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. , 2006, Diabetes.